The currency changes the price
Synaptics rose 14.16% to $121.18 before the open; buyer onsemi also gained 6.22%. These are October 2 extended-hours readings, not regular-session closing prices. The preceding change is concrete: a promise of 1.35 onsemi shares for each Synaptics share became $123 in cash without interest. The promised payment to a target shareholder no longer moves with the buyer’s stock.[1]
The comparison baseline matters. onsemi’s preceding close was $80.08, valuing the old ratio at $108.11. The cash payment is about 13.8% above that current equivalent and carries a 15.9% premium to Synaptics’ $106.15 close. June’s roughly $7 billion enterprise value and the new announcement’s approximately $5.7 billion aggregate consideration use different valuation scopes. Subtracting them to claim an exact saving on a consistent basis would be misleading.[1]
The buyer’s changing burden
June’s structure envisaged approximately 12% of the fully diluted combined company and a board representative for Synaptics shareholders. The cash amendment removes that common-stock issuance and board-seat requirement. onsemi instead uses cash and borrowing capacity: Morgan Stanley Senior Funding committed up to $2.45 billion of senior secured term loans for part of the consideration and expenses. The commitment does not cover the entire purchase price, and obtaining financing is not a closing condition.[1]
I read the buyer’s rise as consistent with reduced common-stock issuance and expectations of earlier earnings accretion finding support together. El-Khoury now expects adjusted earnings-per-share accretion at closing rather than within 18 months. That is a forecast, not realized profit. Sector movements or thin premarket trading could also contribute to the same move; these readings do not distinguish those explanations. Conversion of unvested employee awards into onsemi awards also means potential dilution has not disappeared entirely.[1]
Fixed cash, uncertain closing
The certainty gained by Synaptics owners concerns the payment currency. Completion still requires shareholder and regulatory approvals, with the companies targeting mid-2027. The unsolicited third-party bidder and its price were not disclosed. The cash revision cannot establish that a higher competing bid is available. onsemi’s anticipated additional revenue and production-insourcing benefits are also company expectations beyond the previously announced $200 million in annual run-rate synergies.[1]
Both shareholder calculations meet in the same contract: the seller reduces exposure to onsemi’s future stock price while the buyer assumes financing exposure. That offers a plausible mechanism for a joint rise, without establishing a durable increase in value. The economic weight of the buyer’s accretion claim depends on debt costs and delivery of the anticipated operating benefits. If sector movements explain the rally, my reading may place too much weight on the contract change. Fixed cash at $123 simplifies the target owner’s payment calculation and shifts the buyer’s calculation toward its balance sheet and operating results.[1]